Objective: Statins and hormone therapy (HT), often used concurrently in postmenopausal women, have antagonist effects on the risk of venous thromboembolism (VTE). Methods: We conducted a nested case-control study within a population-based cohort of women aged 50–79 years between January 1, 1987 and March 1, 2008, who were identified from the UK General Practice Research Database.

READ FULL ARTICLE Curated publisher From Lww